Search hospitals > Ontario > TORONTO
Centre for Addiction and Mental Health
Claim this profileTORONTO, Ontario M5T 1R8
Global Leader in Depression
Global Leader in Major Depression
Conducts research for Depression Treatment
Conducts research for Schizophrenia
Conducts research for High Risk for Psychosis
279 reported clinical trials
36 medical researchers
Summary
Centre for Addiction and Mental Health is a medical facility located in TORONTO, Ontario. This center is recognized for care of Depression, Major Depression, Depression Treatment, Schizophrenia, High Risk for Psychosis and other specialties. Centre for Addiction and Mental Health is involved with conducting 279 clinical trials across 220 conditions. There are 36 research doctors associated with this hospital, such as Daniel Blumberger, MD, Ariel Graff, MD, PhD, Philip Gerretsen, MD, PhD, and Bernard Le Foll, MD.Top PIs
Daniel Blumberger, MDCentre for Addiction and Mental Health8 years of reported clinical research
Studies Major Depression
Studies Depression Treatment
13 reported clinical trials
23 drugs studied
Ariel Graff, MD, PhDCentre for Addiction and Mental Health1 year of reported clinical research
Studies Schizophrenia
Studies Psychosis
7 reported clinical trials
10 drugs studied
Philip Gerretsen, MD, PhDCentre for Addiction and Mental Health1 year of reported clinical research
Studies Schizophrenia
Studies Mild Cognitive Impairment
7 reported clinical trials
10 drugs studied
Bernard Le Foll, MDCenter for Addiction and Mental Health3 years of reported clinical research
Studies Methamphetamine Abuse
Studies Methamphetamine Addiction
7 reported clinical trials
8 drugs studied
Clinical Trials running at Centre for Addiction and Mental Health
Depression
Schizophrenia
Bipolar Disorder
Major Depression
Depression Treatment
Alcoholism
Obsessive-Compulsive Disorder
Mild Cognitive Impairment
Cannabis Abuse
Problem Behavior
Escitalopram + Brexpiprazole
for Depression
This is a study that will test a predictive biomarker algorithm based on results from a previous study. The goal of this study is to integrate clinical, imaging, EEG, and molecular data across 8 sites to predict treatment outcome for patients experiencing a major depressive episode (MDE).
Recruiting3 awards Phase 48 criteria
Cannabis Abstinence
for Depression
The prevalence of major depressive disorder (MDD) is \~5.0%, and rates of co-occurring SUDs in these patients approach 40-50%. Specifically, rates of co-morbid cannabis use disorder (CUD) in patients with MDD are elevated 2-3 fold compared to 2.9% in the general population, and is associated with poorer treatment outcomes and impaired cognitive and psychosocial functioning in comparison to MDD patients without CUD. Most studies of cannabis use in MDD are cross-sectional in design, and therefore causal relationships are unclear. This study investigates the effects of cannabis abstinence over a 28-day period in patients with MDD with co-occurring CUD using a randomized controlled design, namely contingent reinforcement.
Recruiting1 award N/A
Psilocybin
for Chronic Pain and Depression
Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to assess the feasibility, tolerability, and preliminary efficacy of psilocybin therapy for adults with chronic neuropathic pain and co-morbid treatment resistant depression.
Recruiting1 award Phase 28 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Centre for Addiction and Mental Health?
Centre for Addiction and Mental Health is a medical facility located in TORONTO, Ontario. This center is recognized for care of Depression, Major Depression, Depression Treatment, Schizophrenia, High Risk for Psychosis and other specialties. Centre for Addiction and Mental Health is involved with conducting 279 clinical trials across 220 conditions. There are 36 research doctors associated with this hospital, such as Daniel Blumberger, MD, Ariel Graff, MD, PhD, Philip Gerretsen, MD, PhD, and Bernard Le Foll, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.